Related Experiment Video
Updated: Jul 17, 2025
07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
Pharmacogenomic Germline Testing: Applications in Oncology Nursing
Joshua Germany1, Janet Kueber1
1Prisma Health Cancer Institute.
Clinical Journal of Oncology Nursing
|September 7, 2023
Summary
Pharmacogenomic testing is increasingly used in oncology to personalize cancer treatments. This approach helps doctors prescribe medications that are both safer and more effective for individual patients.
Area of Science:
- Oncology
- Pharmacogenomics
- Clinical Practice
Background:
- The integration of pharmacogenomics into clinical settings, particularly in oncology, is expanding.
- Pharmacogenomic germline testing offers a pathway to optimize drug selection and dosage.
Purpose of the Study:
- To highlight the growing implementation of pharmacogenomics in clinical oncology.
- To underscore the utility of pharmacogenomic germline testing for enhancing medication safety and efficacy.
Main Methods:
- Review of current clinical practices in pharmacogenomic implementation.
- Analysis of the role of germline testing in treatment personalization.
Main Results:
- Increased adoption of pharmacogenomic strategies in oncology practice.
- Demonstrated potential for improved patient outcomes through tailored pharmacotherapy.
Conclusions:
- Pharmacogenomic germline testing is a valuable tool for developing and prescribing safer, more effective cancer treatments.
- Further integration of pharmacogenomics promises to advance precision medicine in oncology.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
01:27Nursing Ethical Principles II
1.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.0K
01:12Analysis of Population Pharmacokinetic Data
291
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
291